Related Experiment Video
Updated: Nov 11, 2025

05:02
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
3.6K
Metabolic Vulnerabilities in Brain Cancer.
Danielle Morrow1, Jenna Minami1, David A Nathanson2
1Department of Molecular and Medical Pharmacology, University of California Los Angeles.
Neurosurgery Clinics of North America
|March 30, 2021
Summary
Glioblastomas reprogram metabolism for growth and survival. Understanding these metabolic changes and their drivers is key to developing new glioblastoma therapeutics.
Area of Science:
- Oncology
- Cancer Metabolism
- Neuro-oncology
Background:
- Glioblastomas (GBMs) display significant metabolic alterations to fuel rapid tumor growth, invasion, and resistance to therapy.
- Key metabolic pathways, including glycolysis, oxidative phosphorylation, and biosynthesis, are dysregulated in GBMs.
Purpose of the Study:
- To elucidate the critical metabolic adaptations in glioblastoma.
- To highlight the influence of both genetic and microenvironmental factors on GBM metabolism.
- To underscore the importance of understanding metabolic reprogramming for therapeutic development.
Main Methods:
- This study is a review and synthesis of existing research on glioblastoma metabolism.
- Analysis of genetic landscapes and tumor microenvironment characteristics.
- Integration of data on metabolic pathway alterations.
Main Results:
- GBMs exhibit altered glycolytic flux, oxidative phosphorylation, pentose phosphate pathway, fatty acid metabolism, and nucleic acid biosynthesis.
- Both intrinsic genetic factors and extrinsic brain tumor microenvironment elements shape GBM metabolism.
- Metabolic reprogramming is essential for glioblastoma's aggressive phenotype.
Conclusions:
- Targeting altered metabolism in glioblastoma presents a promising therapeutic avenue.
- A comprehensive understanding of the interplay between genetic and environmental factors in modulating GBM metabolism is crucial for effective treatment strategies.
- Further research into metabolic vulnerabilities could lead to novel drug targets for glioblastoma.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Electron Transport Chain: Complex I and II
16.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
16.6K

